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ARF GTPases and their GEFs and GAPs: 
concepts and challenges
ABSTRACT Detailed structural, biochemical, cell biological, and genetic studies of any gene/
protein are required to develop models of its actions in cells. Studying a protein family in the 
aggregate yields additional information, as one can include analyses of their coevolution, 
acquisition or loss of functionalities, structural pliability, and the emergence of shared or 
variations in molecular mechanisms. An even richer understanding of cell biology can be 
achieved through evaluating functionally linked protein families. In this review, we summarize 
current knowledge of three protein families: the ARF GTPases, the guanine nucleotide ex-
change factors (ARF GEFs) that activate them, and the GTPase-activating proteins (ARF GAPs) 
that have the ability to both propagate and terminate signaling. However, despite decades 
of scrutiny, our understanding of how these essential proteins function in cells remains frag-
mentary. We believe that the inherent complexity of ARF signaling and its regulation by GEFs 
and GAPs will require the concerted effort of many laboratories working together, ideally 
within a consortium to optimally pool information and resources. The collaborative study of 
these three functionally connected families (≥70 mammalian genes) will yield transformative 
insights into regulation of cell signaling.
INTRODUCTION
Members of the family of regulatory GTPases that include ARFs, 
ARF-like (ARLs), and SARs have emerged as key regulators of cellu-
lar signaling involved in almost all aspects of cell biology (Tables 1–
3, Figure 1, and Supplemental Tables I–III) (D’Souza-Schorey and 
Chavrier, 2006; Donaldson and Jackson, 2011; Jackson and Bouvet, 
2014). Their importance is underscored by findings showing that 
complete or conditional deletions or mutations result in embryonic 
lethality or organ-specific defects, with links to a variety of diseases 
(Table 4) (Seixas et al., 2013; Zhang et al., 2013). ARF family GTPases 
control key cellular processes, including bidirectional membrane 
trafficking (secretion and endocytosis), ciliogenesis, lipid metabo-
lism, energy use, motility, division, apoptosis, and transcriptional 
regulation. Like all regulatory GTPases, ARF family GTPases operate 
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GTPase Localization Function(s) Interactors
1 Arf1 Cytosol, Golgi Recruitment of coat complexes, 
activation of PLD, PI kinases
COP-I, GGAs, MINTs, Cholera toxin, 
Arfaptin, MKLP1, ARF GEFs, ARF GAPs
2 Arf3 Cytosol, Golgi Recruitment of coat complexes, 
activation of PLD, PI kinases
COP-I, GGAs, MINTs, Cholera toxin, 
Arfaptin, MKLP1, ARF GEFs, ARF GAPs
3 Arf4 Cytosol, Golgi, endosomes COP-I, GGAs, MINTs, Cholera toxin, 
Arfaptin, MKLP1, ARF GEFs, ARF GAPs
4 Arf5 Cytosol, Golgi, endosomes Recruitment of coat complexes, 
activation of PLD, PI kinases
COP-I, GGAs, MINTs, Cholera toxin, 
Arfaptin, MKLP1, ARF GEFs, ARF GAPs
5 Arf6 PM, endosomes, RE, cortical 
actin
Cortical actin rearrangement, 
endocytosis, PLD activation
β-arrestin, POR1, PLD, Cytohesins, 
MKLP1, FilGAP
6 Arl1 Golgi, TGN Endosome–Golgi secretory traffic, 
LD formation
Arfaptin, MKLP1, PDEd, HRG4, Golgins, 
GRIP-domain proteins
7 Arl2 Cytosol, mitochondria, centro-
somes, basal bodies, cilia, RRs
Tubulin heterodimer assembly, mito-
chondrial fusion, Prenyl-protein traffic
TBCD/β-tubulin, TBCD, ELMOD1-3, 
BART/ARL2BP, PDEd, HRG4/UNC119
8 Arl3 Cytosol, centrosomes, cilia, mi-
totic spindle, midbody, Golgi
Cytokinesis, Prenyl- and Myr-protein 
traffic
PDE6δ, HRG4/UNC119, Golgins, 
ARL13B, BART/ARL2BP
9 Arl4a Cytosol, nucleus, TGN, endo-
somes, PM
Endosome–Golgi traffic, actin 
remodeling, cell migration
ELMO, GCC185, Robo1, Cytohesin2
10 Arl4c Cytosol, nucleus, PM Cholesterol traffic, filopodia, cell 
migration, tumorigenesis
α-Tubulin, filamin-A, Cytohesin2
11 Arl4d Cytosol, mitochondria, nucleus, 
PM, actin
Actin remodeling, neurite outgrowth HP1, importin-α, Cytohesin2,
12 Arl5a Nucleus Endosome–Golgi traffic HP1α, GARP, Ragulator
13 Arl5b Nucleus Endosome–Golgi traffic HP1α, GARP, Ragulator
14 Arl5c
15 Arl6 Cilia BBSome, Sec61β
16 Arl8a Lysosomes, phagolysosomes Lysosomal traffic and fusion SKIP-kinesin1b, HOPS complex
17 Arl8b Lysosomes, phagolysosomes Lysosomal traffic and fusion SKIP-kinesin1b, HOPS complex
18 Arl9
19 Arl10 Nuclei, mitochondria
20 Arl11 p-ERK
21 Arl13a
22 Arl13b Cilia, EE, CDRs, centrosomes Regulation of ciliary formation/main-
tenance, axoneme, Hh signaling, EEs
ARL3, INPP5E, PDE6δ, tubulin, FIP5, 
UBC9, MYH9
23 Arl14
24 Arl15 Cytosol, Golgi Genetic links to adiponectin levels 
and type 2 diabetes
ASAP2
25 Arl16 Cytosol, mitochondria, nucleus, 
cilia
RIG-I
26 Arfrp1 trans-Golgi Recruitment of Arl1 and 
Golgin-97/245 to trans-Golgi
Sec7-1, Cytohesin
27 Sar1a ER
28 Sar1b ER
29 Trim23 Lysosomes, Golgi, 
autophagosomes
Ubiquitin ligase, viral infection, 
membrane trafficking
UBE2D2, TBK1, Cytohesin1
National Center for Biotechnology Information (NCBI) gene names are listed, along with cellular localization, identified functions, and protein interactors. Abbrevia-
tions used include CDR, circular dorsal ruffles; EE, early endosomes; PLD, phospholipase D; PM, plasma membrane; RE, recycling endosomes; RRs, rods and rings. 
Additional information is included in Supplemental Table I.
TABLE 1: Human ARF family GTPases.
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as “molecular switches” by interconverting between inactive (GDP-
bound) and active (GTP-bound) conformations. Upon binding GTP, 
the activated GTPases alter their conformations, which increases 
their affinity for effectors and can alter their localization in cells, each 
of which contributes to the generation of a specific biological out-
put. Activated (GTP-bound) ARF family GTPases propagate their 
effects through a specific redistribution of effectors (e.g., recruit-
ment to a membrane), allosteric activation of effector enzymatic 
activity, conformational changes within the effector resulting in in-
creased affinity for other cellular components (proteins, lipids, etc.), 
or a combination of such changes. As a consequence, the signal 
output of these GTPases is tightly controlled by the regulated bind-
ing of GTP and the half-life of the activated state. These are in turn 
controlled by the stimulation of the release of bound GDP (to allow 
GTP to bind spontaneously) by guanine nucleotide exchange 
factors (GEFs) and of their intrinsic GTPase activity by GTPase- 
activating proteins (GAPs) (Casanova, 2007; Inoue and Randazzo, 
2007; Randazzo et al., 2007; Bui et al., 2009; Spang et al., 2010; East 
and Kahn, 2011; Wright et al., 2014; Vitali et al., 2017). Thus, the 
triad of GEF–GTPase–GAP can be viewed as a minimal component 
in signaling pathways that alter a large fraction of cellular behaviors. 
Yet, despite their clear importance in cell biology and links to human 
pathologies, our understanding of the pathways involved and mole-
cular mechanisms remain fragmentary. In this review, we briefly sum-
marize the known roles of the ARF family GTPases, their GEFs and 
GAPs, their localization in cells, and their interactors. Rather than 
describing in detail any one of the many pathways in which they 
operate, we instead emphasize the extensive overlap in specificities 
and actions between family members, as this represents the largest 
challenge to achieving a deep understanding of their mechanisms 
of action. Because every pathway requires the minimum GEF–
GTPase–GAP triad, we argue for a systematic approach to study 
each family and the three families together. We end our review by 
highlighting some key questions and challenges in ARF signaling, 
and hope that it inspires more collaborative efforts to address the 
large, complex, but vitally important area of ARF signaling.
ARF FAMILY GTPASES
Families of ARF GTPases and their cellular functions
Included within the ∼30 members of the mammalian ARF family are 
the six “true ARFs” (humans lack ARF2, thus the discrepancy be-
tween this number and Table 1), the 21 ARF-like (ARL) proteins, two 
SARs, and Trim23 (Table 1; additional information included in Sup-
plemental Table I) (Li et al., 2004; Kahn et al., 2006). The six mam-
malian ARFs are highly conserved, sharing > 65% sequence identity, 
and perform similar and/or overlapping functions. ARLs are more 
divergent, sharing typically 40–60% identity, and largely perform 
distinct cellular functions. The two mammalian SARs share ∼90% 
GEF Localization Function(s) Interactors
1 Arfgef1/BIG1 TGN, sorting endosomes Activation of Arf1/3, recruitment of 
AP1/AP3, myelination
Arl1, Arf1/3, ARF4/5
2 Arfgef2/BIG2 TGN, sorting endosomes Activation of Arf1/3, recruitment of 
AP1/AP3
Arl1, Arf1/3, ARF4/5
3 Cyth1 PM Cell adhesion/migration, integrin 
regulation
GRASP/tamalin, CNKSR1-3, CASP, 
Arl4A, Arl4D, Arf6
4 Cyth2/ARNO PM, REs, Ruffles Cell adhesion/migration, integ-
rin regulation, actin remodeling, 
endosome traffic
GRASP/tamalin, CNKSR1-3, CASP, 
Arl4A, Arl4D, Arf6, paxillin, RLIP76, 
β-arrestin, pallidin
5 Cyth3/ARNO3/GRP1 PM, (Glut4-positive) 
endosomes
Glut4 exocytosis, cell migration GRASP/tamalin, CNKSR1-3, CASP, 
Arl4A, Arl4D, Arf6
6 Cyth4
7 GBF1 Golgi Membrane traffic at cis-Golgi p115, Rab1b, COG4, γ-COP, 
GGA1-3, ATLG, Gmh1
8 Iqsec1/BRAG2/GEP100 PM Integrin endocytosis/cell adhesion 
regulation of AMPA receptor traffic
Calmodulin, MAP4K4, Arf5, Arf6
9 Iqsec2/BRAG1 PSDs Regulation of AMPA receptor 
traffic
Calmodulin, PSD95, IRSp53, Arf6
10 Iqsec3 PSDs Regulation of GABAergic synapse 
formation
Calmodulin, gephyrin, Arf6
11 Psd/EFA6 PM, tight junctions, 
axons, PSDs, endosomes
Tight junction formation, epithelial 
lumen formation
α-Actinin-1, 4, Arf6
12 Psd2/EFA6C
13 Psd3/EFA6D
14 Psd4/EFA6B PM, epithelial tight 
junctions
Tight junction formation, epithelial 
lumen formation
α-Actinin-1, 4, Arf6
15 Fbox8
NCBI gene names are listed, along with cellular localization, identified functions, and protein interactors. Abbreviations used include PM, plasma membrane; PSD, 
postsynaptic densities, RE, recycling endosomes; TGN, trans-Golgi network. Additional information is included in Supplemental Table II.
TABLE 2: Human ARF GEFs.
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primary sequence identity (but < 30% to any other family member), 
and have a specialized role in traffic from the endoplasmic reticulum 
(ER) to the Golgi. The ARF family GTPases are distinct from the other 
families of small, regulatory GTPases (RAS, RHO, RAB) in having an 
N-terminal extension of ∼14 amino acids and covalent modifications 
at or near this end. All six ARFs are N-myristoylated, while ARLs are 
GAP Localization Function(s) Interactors
1 Arfgap1 Golgi ER protein retrieval γ-Adaptin (AP-1), KDEL receptor/
ERD2, p24
2 Arfgap2 Golgi
3 Arfgap3 TGN, EEs EE–LE transport of M6PR and EGFR γ-COP (COPI), GGA1/2
4 Acap1/CENTB1 Rab11 REs Integrin and TfnR recycling β1-Integrin, TfnR, clathrin heavy 
chain
5 Acap2/CENTB2 PM, phagocytic cup, ARF6 
endosomes
Neurite outgrowth, FcγR-mediated 
phagocytosis
Rab35
6 Acap3/CENTB5 Neurite outgrowth, neuronal 
migration
7 Adap1/CENTA1 Membrane ruffles, mito-
chondria, dendrites, synapse
Salmonella invasion, beta2-
AR internalization, dendritic 
differentiation
Kif13b
8 Adap2/CENTA2
9 Agap1 AP-3 endosomes Endosome–lysosome transport AP-3, Kif2A
10 Agap2/PIKE FAs, Rab4/AP-1endosomes Cell migration, neurite outgrowth, 
invasion, TfnR recycling
FAK, RACK1, Akt, Homer, AP-1
11 Agap3 Endosomes
12 Agfg1/HRB, RIP Clathrin/AP-2/EPS15 
vesicles
TfnR endocytosis, HIV-1 replication Rev
13 Agfg2
14 Arap1 EEs, CDRs, podosomes EGFR endocytosis, macropinocyto-
sis, secretory lysosomes
CIN85, AP-3
15 Arap2 FAs, APPL EEs FA turnover, SF formation, integrin 
endocytosis
RhoA, Arf6, APPL1
16 Arap3 Podosome-like adhesions Cell migration, invasion, RhoGAP 
stimulation
Rap1, RhoGAP
17 Asap1 PM, FAs, podosomes/inva-
dopodia, CDRs
Cell migration, invasion, SF forma-
tion, integrin and EGFR recycling
FAK, Crk, CrkL, Src, cortactin, 
NM2A, PRKD2, CIN85, CDAP
18 Asap2 Cell periphery, phagocytic 
cup
Cell migration, FcγR-mediated 
phagocytosis
Selenoprotein K
19 Asap3 PM, CDRs Cell migration, integrin recycling, 
invasion
Grb2
20 Git1 FAs, SNX27 endosomes, 
REs, EEs
Cell migration, invasion, EGFR 
traffic/degradation
PIX, Arf6, paxillin, MEK1, FAK, 
SNX6
21 Git2 PM, FAs Cell migration, invasion, beta2-
Adrenergic R down-regulation
Vav2, paxillin, GRKs
22 Smap1 PM TfnR endocytosis Clathrin heavy chain
23 Smap2 EE, TGN EE–TGN transport Clathrin heavy chain, CALM
24 ELMOD1 Golgi, nuclear speckles, LDs
25 ELMOD2 ER, mitochondria, LDs, cen-
trosomes, RRs
Mitochondrial fusion ARL2, other ARF family GTPases
26 ELMOD3 PM, actin, lagging edge
27 RP2 PM, microtubules, nucleus Ciliary traffic ARL3, UNC119, G protein β1
NCBI gene names are listed, along with cellular localization, identified functions, and protein interactors. Abbreviations used include CDR, circular dorsal ruffles; 
EE, early endosomes; EGFR, epidermal growth factor receptor; FA, focal adhesions; LD, lipid droplets; LE, late endosomes; PM, plasma membrane; RE, recycling 
endosomes; RRs, rods and rings; SF, stress fibers. Additional information is included in Supplemental Table III.
TABLE 3: Human ARF GAPs.
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myristoylated (e.g., ARL1), palmitoylated (e.g., ARL13B), or acety-
lated (e.g., ARFRP1), with each modification critical for activity. In 
this section, we summarize briefly the actions of the different ARF 
GTPases. This should not be taken as an exhaustive description of 
their actions, and we apologize to the many researchers whose work 
is not included in the interest of space.
The ARFs are best known for their roles in recruitment of coat 
proteins/complexes and initiation of vesicle formation in membrane 
trafficking, particularly at the Golgi. However, a brief glance at 
Figure 1, which depicts localizations for all ARF family members, as 
well as the known GEFs and GAPs, reveals far more complexity in 
locations and presumed functions. ARFs are found not only in all 
regions of the Golgi, but also at the plasma membrane (PM), endo-
somes, lipid droplets, and midbodies. ARFs often show overlapping 
distribution (e.g., ARF1, 4, and 5 localize to the cis-Golgi), and one 
ARF can localize to multiple sites (e.g., ARF1 can be recruited to the 
Golgi, lipid droplets, and the PM; however, it is likely that a large 
cytosolic pool remains). ARFs have both redundant and distinct 
functions, as seen in studies showing that small interfering RNA–me-
diated knockdown of any one ARF1/3/4/5 yielded no obvious phe-
notypes, while each double knockdown of distinct pairs of these 
GTPases resulted in specific phenotypes (Volpicelli-Daley et al., 
2005). ARFs affect cellular processes by recruiting effectors. The 
term “effector” is used herein to indicate a protein that binds pref-
erentially to the activated (GTP-bound) form, resulting in a signal or 
output that changes some aspect of cell biology. There are more 
than 20 known ARF effectors and most of these are essential com-
ponents in membrane traffic in all cells (Table 1). The best-character-
ized ARF effectors are adaptors for coat proteins or the coat pro-
teins themselves, including both monomeric (e.g., GGAs or MINTs) 
(Boman et al., 2000; Dell’Angelica et al., 2000; Hill et al., 2003) and 
FIGURE 1: Subcellular localization of the ARF family GTPases, ARF GEFs, and ARF GAPs. A 
schematic cell with organelles (in red) showing the localization of the GTPases (in light blue), 
GEFs (in purple), and GAPs (in green). More detailed information for these localizations is 
provided in references cited in the text.
oligomeric complexes (e.g., COPI, AP-1, 
AP-3, and AP-4) (Serafini et al., 1991; 
Stamnes and Rothman, 1993; Traub et al., 
1993; West et al., 1997; Ooi et al., 1998; 
Hirst et al., 1999; Drake et al., 2000; Donald-
son and Jackson, 2011). ARFs also recruit 
non-coat proteins to membranes (e.g., gol-
gin-160, GCC88) (Derby et al., 2004; Gilbert 
et al., 2018) and can activate lipid-modifying 
enzymes (e.g., phospholipase D, PI(4) 
5- kinase) (Brown et al., 1993; Cockcroft 
et al., 1994; Honda et al., 1999; Jones et al., 
2000) and/or lipid transporters (e.g., FAPP1) 
(Godi et al., 2004). ARF1, ARF3, and ARF6 
are implicated in cell division and/or cytoki-
nesis, but the effectors involved remain to 
be identified (Altan-Bonnet et al., 2003; 
Hanai et al., 2016; Nakayama, 2016). ARF6 
appears to act predominantly in the cell pe-
riphery, where it regulates both endosomal 
recycling and cortical actin dynamics, which 
are also linked to RAC GTPase signaling 
(Donaldson, 2003; Schweitzer et al., 2011).
ARLs localize to and have functions in 
processes involving tubulin/microtubules at 
centrosomes, spindles, midbodies, basal 
bodies, and cilia (Figure 1). ARLs are much 
more divergent in action, with some ARLs 
functioning in parallel with those of the 
ARFs in membrane traffic, while others reg-
ulate completely different processes. For 
example, ARL1 is most closely related to ARFs in primary sequence, 
localizes to the trans-Golgi network (TGN), and acts in membrane 
trafficking through its ability to recruit proteins to that site (Yu and 
Lee, 2017). At the TGN, ARL1 effectors include BIG1 (an ARF GEF), 
Golgin-97, and Golgi-245. ARL1 also localizes to sorting endo-
somes, where it recruits BIG1 to activate ARF1 and ARF3 (D’Souza 
et al., 2014). In yeast, GTP-bound ARL1 is located at the Golgi com-
plex and facilitates the exit of vesicles from the TGN (Munro, 2005). 
In mammalian cells, ARL1 is involved in cell polarity (Lock et al., 
2005); innate immunity (Murray and Stow, 2014); and the secretion 
of insulin (Gehart et al., 2012), chromogranin A (Cruz-Garcia et al., 
2013), and matrix metalloproteinases (Eiseler et al., 2016). In marked 
contrast, ARL2 localizes to multiple cellular sites to perform surpris-
ingly distinctive functions. ARL2 is found in 1) cytosol, as a 1:1:1 tri-
mer with the tubulin cochaperone cofactor D (TBCD) and β-tubulin, 
and is required for αβ-tubulin biogenesis (Francis et al., 2017a,b); 
2) the mitochondrial intermembrane space, where it promotes mito-
chondrial fusion (Newman et al., 2014, 2017); 3) at centrosomes 
(Zhou et al., 2006); 4) in the nucleus; and 5) at rods and rings, which 
are implicated in guanine nucleotide metabolism (Schiavon et al., 
2018). Despite its involvement in such disparate activities, ARL2 is 
ubiquitously expressed in eukaryotes and has not duplicated into 
paralogues that might allow separation of functions (Francis et al., 
2016). One intriguing hypothesis born from these observations is 
that the use of a shared cell regulator at multiple locations might 
serve as a means of communication between those sites, a phenom-
enon termed “higher-order signaling” (Francis et al., 2016).
ARL2 and ARL3 display both overlapping and distinct actions 
and interactions (Van Valkenburgh et al., 2001; Zhou et al., 2006). 
Both are linked to microtubules, localize to centrosomes, and share 
the ability to bind PDEδ in a GTP-dependent manner and promote 
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the release of isoprenylated cargoes (Van Valkenburgh et al., 2001; 
Ismail et al., 2011). While they both also bind HRG4, only ARL3 
binding results in the release of N-myristoylated cargoes from this 
carrier (Ismail et al., 2012). ARL2 is involved in tubulin heterodimer 
biogenesis, while ARL3 functions in cytokinesis (Zhou et al., 2006). 
ARL3 also appears to act at the Golgi, though how such action may 
be integrated with its other roles remains unclear (Zhou et al., 2006). 
ARL3 is essential in photoreceptor cells that employ an elaborate 
variation of cilia in outer segments (Panic et al., 2003; Zhou et al., 
2006; Hanke-Gogokhia et al., 2018) (Table 4). An unexpected find-
ing is that ARL3 is activated by ARL13B (Gotthardt et al., 2015; 
Ivanova et al., 2017), which raises the possibility that other ARLs may 
also serve as ARL GEFs, particularly as so few ARL GEFs have been 
identified to date.
Primary cilia are a major site of action for four different ARLs: 
ARL3, 6, 13B, and 16 (Figure 1). Each of these GTPases plays a criti-
cal role(s) in ciliary biology, with details and mechanisms still under 
investigation. Their activity is particularly important during develop-
ment (Zhang et al., 2013), as mutations in these genes cause ciliopa-
thies and developmental disorders in mammals (Chiang et al., 2004; 
Caspary et al., 2007; Wiens et al., 2010; Liew et al., 2014; Alkanderi 
et al., 2018) (Table 4). Although best known for its role in cilia and in 
Hedgehog signaling, ARL13B also functions outside the cilium by 
interacting with a kinesin to facilitate axon guidance (Higginbotham 
et al., 2012; Casalou et al., 2014). ARL13B is also distinctive, as it is 
nearly twice the size of other GTPases in the ARF family, having a 
C-terminal domain as large as the GTPase domain. ARL6 also goes 
by the name BBS3, as its mutation is linked to Bardet-Biedl syn-
drome and defects in Wnt signaling (Chiang et al., 2004; Wiens 
et al., 2010; Zhang et al., 2011). ARL6 acts in ciliary trafficking 
through recruitment of the BBSome complex (Jin and Nachury, 
2009; Jin et al., 2010; Ye et al., 2018).
The theme of ARF GTPases sharing a similar function is evident 
in the recruitment of Golgins to the Golgi. As mentioned earlier, 
ARFs recruit Golgin-160 and GCC88 to the Golgi, while ARL1 re-
cruits Golgin-97 and Golgin-245 (Derby et al., 2004). This is just one 
of several examples in which ARLs and ARFs act in a common 
pathway. However, ARL4A, which performs a similar function by in-
teracting with GCC185 at the TGN to modulate the integrity of the 
Golgi, also has a completely distinct function in endosome-to-Golgi 
transport (Lin et al., 2011). ARL4A also plays a role in actin cytoskel-
eton rearrangement involving ELMO/DOCK180-induced RAC 
signaling (Patel et al., 2011). ARL4C and ARL4D modulate actin 
remodeling and cell migration through their interacting partners, 
filamin-A and Cytohesin 2, respectively (Li et al., 2007; Chiang et al., 
2017). Expression of ARL4C in normal epithelial cells promotes 
migration and proliferation, indicating a role in epithelial morpho-
genesis (Matsumoto et al., 2014). Each ARL4 paralogue can recruit 
the ARF GEF Cytohesins to the PM (Hofmann et al., 2007; Li et al., 
2007). ARL5 localizes to the Golgi and influences endosome–Golgi 
traffic through interactions with the GARP complex (Rosa-Ferreira 
et al., 2015), while ARL8 also acts in vesicular trafficking, predomi-
nantly at lysosomes, where it can influence the motility of this organ-
elle (Khatter et al., 2015). With the exceptions of ARL2 and ARL3, 
which act in cytosol to affect the assembly and dynamics of microtu-
bules and centrosomes, almost all ARFs and ARLs act at membranes. 
(Though nothing is currently known about the locations and func-
tions of ARLs 9, 11, 14, or 15.)
Activated ARF-related protein 1 (ARFRP1) also localizes to the 
TGN and has been implicated in vesicular trafficking of vesicular 
stomatitis virus G protein (Shin et al., 2005; Nishimoto-Morita et al., 
2009), glucose transporters (Hesse et al., 2012), and other PM G
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proteins. ARL1 and its effectors Golgin-97 and Golgin-245 are re-
cruited to the TGN by ARFRP1 (Setty et al., 2003; Zahn et al., 2006). 
In addition to acting in membrane trafficking, ARFRP1 also plays 
roles in regulating metabolism, especially lipid and fat storage. 
Knockout of Arfrp1 in different mouse tissues causes severe meta-
bolic defects (Hommel et al., 2010; Jaschke et al., 2012; Rodiger 
et al., 2018) (Table 4). Despite their similarities to ARFs and ARL1, 
neither GEFs nor GAPs for ARFRP1 have been identified, making 
descriptions of pathways challenging.
Two members of the ARF family are much larger than the 20- to 
25-kDa norm, ARL13B with 428 residues and Trim23/ARD1 with 574 
residues (Supplemental Table I). Homologues of the C-terminal do-
main of ARL13B are not found in other proteins, and we have little 
information on its function, save the presence of a VXPX ciliary lo-
calization motif. Trim23 is a multidomain protein having a RING fin-
ger, two B-boxes, and a coiled-coil motif (thus a tripartite motif 
[TRIM]) (Vichi et al., 2005). These domains have polyubiquitination 
activity and act in the antiviral defense system and adipocyte dif-
ferentiation (Arimoto et al., 2010; Watanabe et al., 2015; Sparrer 
et al., 2017).
The functions and mechanisms of SARs are well characterized. 
SAR1 is activated by the Sec12 GEF, leading to its recruitment to 
the site of protein export from the ER, ERES (ER exit sites) (Figure 
1). Activated SAR1 recruits the Sec23/24 complex and later the 
Sec13/31 complex to form the COPII coat necessary to generate 
COPII vesicles. The Sec13/31 complex promotes the GAP activity 
of Sec23 to “inactivate” SAR that serves to recycle all components. 
Sec12 and Sec23 are an atypical GEF and GAP pair as they lack a 
canonical GEF or GAP domain, and thus 
this regulatory system is of limited use in 
modeling mechanisms of the ARF/ARL 
GEFs and GAPs. Consequently, SARs are 
omitted from further discussion in this 
review.
Structural insight into the actions 
of ARF GTPases
While all ARF family members share the ca-
nonical G domain with nucleotide-sensitive 
switch 1 and 2 loops (Amor et al., 1994), 
they display structural signatures that strik-
ingly distinguish them from other small 
GTPase families (Figure 2) (Pasqualato et al., 
2002). The hallmark of members of the ARF 
family is an allosteric structural feature, 
which allows their nucleotide-binding site to 
communicate with regions located on the 
other side of the GTPase. It is based on an 
interswitch region (as it connects switch 1 
and switch 2), that toggles like a push but-
ton between the inactive and the active con-
formations (Yu et al., 2012). The ability of the 
interswitch to toggle is encoded in a 
conserved sequence signature at the begin-
ning of the switch 2 (Pasqualato et al., 2002). 
In toggling between these two positions, 
the interswitch simultaneously modifies the 
conformation of both the nucleotide-bind-
ing site and the other side of the protein. In 
ARF and related GTPases, the rearrange-
ment of the interswitch is coupled to a vari-
able N-terminal extension, which is autoin-
hibitory in the GDP-bound form and swings out to facilitate 
activation. In ARF GTPases, this region is a myristoylated amphipa-
thic helix that interacts with membranes through the myristoyl group 
and the neighboring residues (Antonny et al., 1997; Liu et al., 2009, 
2010). This is a prerequisite for their activation by GTP, thus coupling 
the activation of the GTPase to its interaction with the membrane 
bilayer (see also the ARF GEFs section).
Because of these major differences compared with classical RAS-
like GTPases, caution is needed when using mutants and fusions to 
manipulate the activation state of ARF GTPases. The glutamine at 
the beginning of switch 2 is generally critical for GAP-stimulated 
GTP hydrolysis (Cherfils and Zeghouf, 2013), and this is also the case 
for ARF GTPases (e.g., Q71 in ARF1 or ARL1, Q70 in ARL2) (Zhang 
et al., 1994; Van Valkenburgh et al., 2001). However, another classi-
cal mutation, a P-loop serine/threonine to asparagine substitution, 
which gives rise to a dominant-negative version in many small 
GTPases by reducing their affinity for guanine nucleotide and titrat-
ing their GEFs, may not function the same in all ARF GTPases (Macia 
et al., 2004). Alternatively, mutation of another threonine, located in 
switch 1, trapped ARF6 in a GDP-bound form, a mutation that could 
in principle also function in related ARF GTPases, many of which 
share the same structural feature. Another important aspect is that, 
given the regulatory role of the N-terminus and the need for lipid 
modifications, ARFs should be tagged only at the C-terminus, and 
even then only with caution (Jian et al., 2010).
ARFs function by binding effectors, and structural studies of 
many ARF/ARL–effector complexes show that ARFs have similar 
conformations in all complexes and bind most effectors in the 
FIGURE 2: Structural determinants of ARF association with membranes and interactors. ARFs 
have four regions that change conformation between GDP- and GTP-bound forms: the canonical 
switch 1 (in orange) and switch 2 (in magenta) that directly sense the nature of the bound 
nucleotide; the myristoylated N-terminal helix (in blue), which is autoinhibitory in ARF-GDP and 
binds the membrane in ARF-GTP; and the interswitch (in red) that functions as a push button to 
ensure allosteric communication between the membrane- and the nucleotide-binding sites. 
GEFs, GAPs, and effectors generally bind to switch 1, switch 2, and/or the interswitch by one 
domain (in light yellow) and carry other domains that bind to the membrane (in light blue). The 
membrane bilayer is denoted in gray.
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same area centered on an invariant triad of aromatic residues in 
the switch/interswitch regions (Khan and Menetrey, 2013). In con-
trast, the effectors bind ARF-GTP through binding sites that are 
distinct in primary, secondary, ternary, and quaternary structures 
(Cherfils, 2014). Thus, the solved structures of known ARF– 
effector complexes do not inform on structural determinants that 
could be used to predict the binding of other effectors to ARF/
ARLs. Interestingly, at least one ARF effector (i.e., coatamer) en-
hances the GTP hydrolytic activity of an ARF GAP, suggesting the 
formation of a ternary ARF-effector-GAP complex. Supporting 
evidence for formation of such a ternary complex is provided by 
a composite structural model for the ARF1/coatamer/ArfGAP1 
complex (Yu et al., 2012) and by the recent cryoelectron micros-
copy study of ARF1/COP1/ArfGAP complex reconstituted on a 
lipid vesicle (Dodonova et al., 2017). A common feature of ARF–
effector interactions is that they are predicted to position 
effectors in precise orientations in apposition to the membrane 
(DiNitto et al., 2007; Liu et al., 2009, 2010; Cherfils, 2014). This 
“solid phasing” will impart orientation constraints for effector 
interactions that are important to produce signals. As a conse-
quence, biochemical assays used to determine affinities for and 
activities of effectors should incorporate membranes and are 
subject to changes in response to different lipid components of 
those membranes.
Regulating ARFs
ARFs are N-myristoylated (a cotranslational covalent modification 
that is not reversible), but this modification, while critical to activity, 
is unlikely to be regulatory. Other posttranslational modifications 
(e.g., phosphorylation, ubiquitination) occur on the GTPases, GEFs, 
and GAPs, but have been largely underexplored. The details of ARF 
activation and deactivation are discussed in the ARF GEFs and ARF 
GAPs sections.
ARF GEFS
Families of ARF GEFs and their cellular functions
ARFs require GEFs to accelerate nucleotide exchange. This is 
likely true of the ARLs as well, though relatively weak affinity for 
guanine nucleotides by ARL2, ARL13B, and perhaps others sug-
gests the possibility of other means of regulating their activation 
process. As no GEFs for ARLs have been identified, except that 
of ARL13B for ARL3 (Gotthardt et al., 2015), this section is limited 
to GEFs that act on mammalian ARFs. The human genome en-
codes 15 ARF GEFs divided into six families based on sequence 
relatedness, domain organization, and phylogenetic analyses: 
GBF, BIGs, Cytohesins, EFA6/Psd, BRAG/IQSec, and FBX (Table 
2, Figure 3A, and Supplemental Table II). All ARF GEFs share a 
common catalytic Sec7 domain (Sec7d) and a mechanism of ac-
tion, but display diversity in their actions and regulation in cells 
(Peyroche et al., 1996; Cherfils and Chardin, 1999; Jackson and 
Casanova, 2000; Casanova, 2007). The locations of ARF GEFs in 
cells parallel those of ARF1-6 at the Golgi, endosomes, and the 
PM (Figure 1). In this section, we briefly describe the actions of 
human ARF GEFs.
GBF1 and BIG1/2 are key regulators of membrane traffic within 
the secretory and endosomal pathways (Wright et al., 2014). GBF1 
preferentially localizes to the Er-Golgi intermediate compartment 
(ERGIC) and the cis-Golgi, where it mediates ARF activation required 
for COPI vesicle formation. GBF1 likely activates ARF1 and ARF4, as 
only the simultaneous removal of these, but not any other pair of 
ARFs, inhibits COPI traffic (Zhao et al., 2002, 2006; Volpicelli-Daley 
et al., 2005; Szul et al., 2007; Manolea et al., 2008). GBF1 also acts 
at the TGN to support the recruitment of BIG1 and BIG2 through 
activating ARF4 and ARF5 (Lowery et al., 2013). GBF1 facilitates 
lipid droplet formation (Ellong et al., 2011; Takashima et al., 2011; 
Bouvet et al., 2013), is detected at PM sites involved in active migra-
tion and chemotaxis (Mazaki et al., 2012; Busby et al., 2017), and in 
some cells facilitates traffic through the glycophosphatidyl-inositol–
enriched endosomal compartments (GEECs) pathway (Gupta et al., 
2009), but the ARFs activated for these functions are unknown. BIG1 
and BIG2 localize to the TGN and endosomes, where they mediate 
ARF activation required for endosome–PM recycling, TGN–PM recy-
cling, TGN–late endosome transport, and in some cells TGN–gran-
ule transport (Shinotsuka et al., 2002a; Zhao et al., 2002). BIG1 and 
BIG2 facilitate the recruitment of the clathrin adaptors AP1 and AP3 
through activation of ARF1 and ARF3 (Pacheco-Rodriguez et al., 
2002; Shinotsuka et al., 2002a,b; Ishizaki et al., 2008). BIG1 seems to 
play additional nontrafficking roles, as it is detected in the nucleus of 
serum-starved cells (Padilla et al., 2004, 2008).
The Cytohesins localize to and regulate endosomal trafficking 
(Figure 1), including the stimulated recycling of the glucose trans-
porter GLUT4, integrins, and other proteins (Caumont et al., 2000; 
Oh and Santy, 2010, 2012; Li et al., 2012; Salem et al., 2015). 
FIGURE 3: Domain organization of ARF GEFs and ARF GAPs. A 
schematic of the domains present in each subfamily of the ARF GEFs 
(A) and ARF GAPs (B). The defining ARF GEF/Sec7 domain and the 
ARF GAP domain are aligned. Protein lengths are not drawn to scale. 
Abbreviations (in alphabetical order): A, ARF GAP lipid-packing sensor 
(ALPS); ANK, ankyrin repeat; BAR, Bin/Amphiphysin/Rvs; BoCCS, 
binder of coatomer, cargo, and SNARE; CALM BD, calm binding 
domain; CB, clathrin box; DCB, dimerization and cyclophilin binding; 
E/DLPPKP8, 8 repeats of this primary sequence (single letter code); 
F-BOX, cyclin F protein interaction motif; FG repeats, multiple copies 
of XXFG repeated; GLD, GTP binding protein–like domain; GRM, 
Glo3 regulatory motif; HDS(1-4), homology downstream of Sec7; 
HUS, homology upstream of Sec7; IQ, isoleucine/glutamine 
calmodulin-binding motif; PBS, Paxillin binding site; PH, pleckstrin 
homology; Pro-rich, proline rich; RA, Ras association; Rho GAP, Rho 
GTPase-activating protein; SAM, sterile α motif; SHD, Spa homology 
domain.
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Cytohesins can be recruited to the PM in response to insulin, epider-
mal growth factor (EGF), or nerve growth factor (NGF) (Venkateswarlu 
et al., 1998a,b), where they are required for signaling by these hor-
mones (Li et al., 2003; Fuss et al., 2006; Hafner et al., 2006; Lim et al., 
2010; Attar and Santy, 2013; Hahn et al., 2013; Pan et al., 2013; Re-
viriego-Mendoza and Santy, 2015). Cytohesins also stimulate Rac ac-
tivation and actin polymerization at the cell periphery (Frank et al., 
1998; Santy and Casanova, 2001; Santy et al., 2005; Li et al., 2007; 
White et al., 2010; Reviriego-Mendoza and Santy, 2015), resulting in 
increased cell migration (Santy and Casanova, 2001; Santy et al., 
2005; Torii et al., 2010; Attar and Santy, 2013). Cytohesins perform 
these functions by activating ARF1 and/or 6. However, all ARF iso-
forms are efficiently activated by Cytohesins in vitro, raising the ques-
tion of how specific ARF isoforms are selected in vivo.
The BRAGs (Brefeldin A–resistant ARF GEF, later renamed IQSecs) 
contain a calmodulin-binding IQ motif in the N-terminal third of each 
protein (Figure 3A). IQSec1 and 3 are highly enriched in the central 
nervous system, while IQSec2 is ubiquitous. IQSecs localize to endo-
somes and the PM in nonneuronal cells, and to postsynaptic densi-
ties in neurons (reviewed in D’Souza and Casanova, 2016) (Figure 1), 
In general, IQSecs appear to control the internalization of adhesive 
and/or signaling molecules. Examples include the adhesion proteins 
dumbfounded (Duf), roughest (rst), and N-cadherin in myoblasts 
(Bach et al., 2010); the semaphorin, Sema3E, and its cognate recep-
tor plexin D1 in endothelial cells (Sakurai et al., 2011); synaptic AMPA 
receptors in neuronal pathfinding (Charych et al., 2004; Scholz et al., 
2010; Elagabani et al., 2016); and β1 integrins in metastasizing breast 
cancer cells (Moravec et al., 2012). IQSecs perform these functions 
through the activation of ARF5 and/or ARF6. Like Cytohesins, IQSecs 
efficiently activate all ARFs in vitro (Peurois et al., 2017), and the 
mechanisms that determine their selectivity in cells remain elusive. 
IQSec1 also acts in the nucleus (Dunphy et al., 2007), raising the 
question of how its various functions are integrated and regulated.
The EFA6 (exchange factor for ARF6)/PSD (pleckstrin homology 
and Sec7 domain) proteins activate ARF6 and regulate actin cyto-
skeleton dynamics at the cell surface (Franco et al., 1999; Macia 
et al., 2001) (Figure 1). They appear to support distinct functions in 
specific cells and during development, as suggested by their varied 
tissue distribution (all EFA6 proteins except EFA6B are abundant in 
brain but are differentially distributed within different brain regions, 
with EFA6C showing the most selective localization to only Purkinje 
cells and the choroid plexus; Matsuya et al., 2005) and changing 
expression levels during development (Sakagami et al., 2006). EFA6 
has been implicated in dendritic branching and spine formation 
(Inaba et al., 2004) and might regulate endocytosis of neurotrans-
mitter receptors (Decressac et al., 2004). It also has been implicated 
in clathrin-mediated endocytosis through a regulatory interaction 
with endophilin (Boulakirba et al., 2014).
FBX8 is the sole representative of the last GEF subfamily and is 
the least understood (Table 2). The role of the N-terminal F-box 
domain is unclear (Figure 3B). Paradoxically, though serving as a 
GEF for ARF6 at the cell surface, it also exhibits a suppressive effect 
on ARF6 activity, perhaps through a poorly described effect on 
mono-ubiquitination of ARF6 (Yano et al., 2008). Interestingly, FBX8 
shows no GEF activity in vitro, raising uncertainty as to whether it is 
a bona fide GEF.
Structural insight into the mechanisms of ARF activation 
by GEFs
All ARF GEFs use the same mechanism to promote nucleotide ex-
change through the highly conserved, catalytic ∼200-residue Sec7 
domain (Sec7d), so named based on homology to the domain in the 
Saccharomyces cerevisiae Sec7 protein (Peyroche et al., 1996). To 
be activated by a Sec7d, ARF-GDP must be primed by membranes 
that displace the autoinhibitory N-terminal helix, thus allowing the 
GEF to promote the toggle of the interswitch and secure ARF-GDP 
on the membrane before GDP dissociation (Renault et al., 2003). 
Next, the Sec7d inserts an invariant glutamate (also called the “glu-
tamic finger”; Beraud-Dufour et al., 1998; Renault et al., 2003) into 
the active site, which competes with the phosphates of GDP to pro-
mote its dissociation and the formation of a nucleotide-free com-
plex that can bind GTP (Goldberg, 1998). Charge-reversal mutation 
of the glutamic finger renders a Sec7d catalytically inactive (Beraud-
Dufour et al., 1998). Thus, in a manner that is unique to ARF GEFs, 
stimulation of GDP/GTP exchange has an absolute requirement for 
a membrane, which can be likened to a cofactor. Interestingly, the 
Sec7d of GBF and BIG is generally, although not always, the target 
of the fungal toxin Brefeldin A, which traps an abortive ARF–GDP–
BFA–Sec7 complex (Peyroche et al., 1999; Mossessova et al., 2003; 
Renault et al., 2003).
Regulating GEFs
ARF signaling is tightly regulated in cells, implying that the activating 
GEFs are catalytically active only at specific times and places. GEFs 
are regulated by multiple molecular mechanisms that impact their 
membrane association and/or catalytic activity. All inactive ARF GEFs 
are cytosolic, but activate ARF only on membranes, suggesting that 
membrane recruitment represents a regulatory step. Recruitment 
strategies differ among the GEFs, albeit some commonalities are 
emerging. GBF1 and BIG1/2 share a common domain architecture 
composed of domains located upstream and downstream of the 
Sec7d, coined HUS and HDS domains, respectively (Mouratou et al., 
2005). These proteins are recruited through an interaction of their 
N-terminal regions (up to the Sec7d) with a small GTPase: Rab1b for 
GBF1 (Alvarez et al., 2003; Monetta et al., 2007) and ARL1 (Christis 
and Munro, 2012; McDonold and Fromme, 2014) and ARF4/5 (Low-
ery et al., 2013) for BIG1 and BIG2. Such a system is reminiscent of 
the “cascade” of Rab GTPases working at several stages of mem-
brane trafficking (Jones et al., 1999; Stalder and Antonny, 2013). The 
C-terminal regions of GBF1 and BIG1/2 are also important, as intact 
HDS domains are required for their membrane association (Mc-
Donold and Fromme, 2014; Chen et al., 2017; Gustafson and 
Fromme, 2017; Meissner et al., 2018; Pocognoni et al., 2018). It is 
likely that multiple domains position these GEFs on the membrane, 
but how such interactions are ordered and whether or not they dis-
play cooperativity is unknown. The catalytic activity of GBF1, BIG1, 
and BIG2 appears to be regulated through allosteric mechanisms. 
The activity of the yeast Sec7p (orthologue of BIG1/2) is stimulated 
through conformational changes induced by binding of Ypt (yeast 
Rab orthologues) GTPases to its N- and C-terminal domains (Mc-
Donold and Fromme, 2014). In addition, binding of ARF-GTP also 
stimulates activity in a forward loop where the generated product 
further activates Sec7d. There are three allosteric binding sites on 
Sec7p, two for Ypts and one for activated ARF, leaving open the 
catalytic GEF site for binding ARF-GDP. Such a regulatory/stimula-
tory effect may ensure a concentrated burst of activated ARFs to lo-
cally recruit a plethora of effectors. However, mammalian BIG1/2 and 
GBF1 do not show an analogous regulatory mechanism. Instead, the 
catalytic activity of GBF1 may be stimulated by a HDS1-phos-
phoinositide (PIP) interaction (Meissner et al., 2018), analogous to 
the PH domain regulating the catalytic activity of BRAG/IQSecs.
Cytohesins, BRAG/IQSecs, and EFA6/PSDs contain a PH domain 
downstream of their Sec7 domain (Figure 3A) that facilitates 
membrane recruitment by interacting with PIPs and other anionic 
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phospholipids and, in some cases, the active forms of ARF/ARL 
GTPases. The binding properties and structural modalities, how-
ever, diverge between the families. The PH domains of Cytohesins 
play multiple roles, including specific recognition of PIP2 and PIP3 
by the canonical lipid-binding site (DiNitto et al., 2003; Cronin et al., 
2004), autoinhibition of the Sec7 active site (DiNitto et al., 2007), 
and implementation of a positive-feedback loop by binding to ARF-
GTP or ARL4-GTP (Cohen et al., 2007; Hofmann et al., 2007; Mal-
aby et al., 2013; Stalder and Antonny, 2013). An important determi-
nant is the polybasic region located immediately downstream of the 
PH domain, which contributes both to autoinhibition and recruit-
ment to the membrane. Other layers of regulation have been de-
scribed. One of these is an autoinhibitory interaction mediated by 
the N-terminal coiled coil, a domain involved in cytohesin dimeriza-
tion. Autoinhibition is relieved by AKT-dependent phosphorylation 
of a threonine residue in the PH domain, which allows the recruit-
ment of Cytohesins to membranes (Li et al., 2012; Hiester and 
Santy, 2013). Phosphorylation of protein kinase C (PKC) sites in the 
polybasic regions of Cyth1 and Cyth2/ARNO also stimulates their 
GEF activity, presumably by destabilizing the autoinhibited state 
(DiNitto et al., 2007). Grp1 lacks these PKC sites but can be phos-
phorylated by AKT on a serine near the catalytic site in the Sec7d 
and a threonine in the β1/β2 loop in the PH domain, thereby influ-
encing GEF activity and PIP affinity/specificity, respectively (Li et al., 
2012).
The PH domains of BRAG/IQSecs differ from those in Cytohesins 
in that they do not autoinhibit the Sec7 domain (Jian et al., 2012; 
Aizel et al., 2013) and they bind several anionic lipids instead of 
recognizing a single phosphoinositide with high specificity (Karan-
dur et al., 2017). PIP2 binding increases their catalytic activity, likely 
by positioning the GEF in an optimal membrane-based orientation 
with respect to the ARF GTPase (Karandur et al., 2017). In contrast 
to Cytohesins, ARF-GTP has no effect on BRAG/IQSec activity. In 
addition, BRAG/IQSecs are unique among the GEFs in their sensi-
tivity to calcium due to the noncanonical IQ motif in the N-terminus 
(Figure 3A), which fits the consensus for binding to calcium-free 
calmodulin. BRAG1/IQSec2 binds to Ca2+-free calmodulin in vitro, 
and addition of Ca2+ causes its dissociation from membranes (Aizel 
et al., 2013; Roy et al., 2016). Whether this dissociation is due to a 
calmodulin-based regulation, to competition of Ca2+ with phospho-
lipids for binding to the PH domain, or both acting in synergy re-
mains to be established but raises the question of possible cross-
talk between Ca2+ and ARF signaling.
EFA6/PSD is also recruited to anionic membranes by its PH 
domain and a polybasic element in its C-terminus, but its activity is 
inhibited by ARF-GTP, indicating negative-feedback regulation 
(Padovani et al., 2014). Its GEF activity is enhanced by direct interac-
tion with endophilin in clathrin-mediated endocytosis (Boulakirba 
et al., 2014).
ARF GAPS
Families of ARF GAPs and their cellular functions
ARF GAPs are defined by the presence of the conserved, catalytic 
GAP domain (Figure 3B), first identified in ArfGAP1, which binds to 
ARF-GTP to promote hydrolysis of GTP to GDP. The human genome 
encodes at least 28 proteins containing an ARF GAP domain or hav-
ing GAP activity (Gillingham and Munro, 2007; Kahn et al., 2008; 
Donaldson and Jackson, 2011) (Table 3; additional information in-
cluded in Supplemental Table III). There are eight additional ARF 
GAP genes on chromosome 10, but it is not known whether these 
are expressed. ARF GAPs are divided into 10 subtypes based on 
sequence similarity and shared domain structure (Figure 3B) 
(Randazzo and Hirsch, 2004; Inoue and Randazzo, 2007; Spang 
et al., 2010). Each GAP subtype, and even members within a par-
ticular subtype, display distinct localizations (Figure 1) and functions, 
and those can be either ARF dependent or ARF independent 
(Gillingham and Munro, 2007; Spang et al., 2010; Donaldson and 
Jackson, 2011; Vitali et al., 2017). An exception is the ELMOD family 
proteins that lack the ARF GAP domain, yet have in vitro activity 
against a wide range of ARF family GTPases, including both ARFs 
and several ARLs (Bowzard et al., 2007; East et al., 2012; Ivanova 
et al., 2014). The three mammalian proteins, ELMOD1-3, share an 
ELMO domain and an apparent catalytic arginine (East et al., 2012). 
Their cellular locations are shown in Figure 1, but are not discussed 
further.
With the well-established role of ARFs in membrane trafficking, 
most studies of ARF GAPs focused in this area, and specifically in 
coat/adaptor recruitment to membranes, predominantly at the 
Golgi and PM (Gillingham and Munro, 2007; Spang et al., 2010; 
Donaldson and Jackson, 2011; Shiba and Randazzo, 2012; Vitali 
et al., 2017). At least six subtypes of GAPs are involved in the recruit-
ment of ARF-dependent adaptors, including the COPI coatomer, 
GGAs, and clathrin and its adaptor AP-3. Because GAPs can inacti-
vate ARFs, the early models posited that GAPs function exclusively 
as terminators of ARF signaling (Weimer et al., 2008). However, the 
role of GAPs is far more complex. Compelling evidence for function 
of GAPs in supporting ARF activities, rather than solely acting as 
signal terminators, initially came from a screen for high-copy sup-
pressors of ARF insufficiency in yeast that showed that all ARF GAPs 
in that organism could compensate for the ARF deficiency (Zhang 
et al., 1998). The idea of GAPs being involved in propagation of an 
ARF signal was further supported by the finding that a number of 
GAPs drive coat assembly and cargo selection during the formation 
of transport vesicles (Yang et al., 2002; Lee et al., 2005; Spang et al., 
2010; Bai et al., 2011; Shiba et al., 2011). These observations sug-
gest that GAPs can serve as ARF effectors, or that ARF activity re-
quires multiple rounds of inactivation/activation cycles that require 
GAPs, or both.
ARF GAPs also regulate the actin cytoskeleton and associated 
adhesive structures (Hoefen and Berk, 2006; Randazzo et al., 2007; 
Ha et al., 2008; Casalou et al., 2016; Zhou et al., 2016; Luo et al., 
2017; Vitali et al., 2017); for example, at least seven GAPs (GIT1, 
GIT2, ASAP1-3, ARAP2, and AGAP2) associate with focal adhesions 
(FAs) and function therein (Figure 1; listed under PM in this figure to 
save space). GAP effects are mediated in part by regulating traffic of 
FA components to the nascent structures and through effects on 
RHO GTPase signaling, including acting as scaffolds for compo-
nents in the Rho family GTPase pathways (Zhao et al., 2000; Lamorte 
et al., 2003; Yin et al., 2005; Frank et al., 2006) and directly binding 
to and altering the functions of actin, non-muscle myosin 2 (Chen 
et al., 2016), and Kif2A (Luo et al., 2016). Some effects on the 
cytoskeleton can be propagated by GAP mutants lacking catalytic 
activity but able to bind ARF-GTP (Randazzo et al., 2000), again 
supporting the role of GAPs as effectors rather than simply signal 
terminators. Some GAPs (e.g., ARAPs) contain both ARF GAP and 
RHO GAP domains, with functions that can be attributed to either 
activity (Miura et al., 2002; Krugmann et al., 2002; Stacey et al., 
2004; Nishiya et al., 2005; Yoon et al., 2006, 2008; Gambardella 
et al., 2011, 2012; Chen et al., 2013, 2014; Luo et al., 2018).
ARF GAPs also affect the activities of protein kinases (e.g., 
AGAP2 binds and activates AKT; Liu et al., 2007; while ARAP2 re-
duces AKT phosphorylation, and thereby its activity, by an unknown 
mechanism; Luo et al., 2018). Thus, a single ARF GAP can affect 
multiple signaling pathways, and multiple ARF GAPs may impinge 
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on a single pathway. Unfortunately, our knowledge of the many 
functions in signaling and integration of multiple signaling pathways 
to elicit distinct phenotypic responses is still fragmentary.
Structural insight into the mechanisms of ARF GAPs
Soon after the discovery of the first ARF GAP (Cukierman et al., 
1995), the role of the catalytic arginine (aka an “arginine finger”; 
Ahmadian et al., 1997; Scheffzek et al., 1998; Cherfils and Zeghouf, 
2013) in the hydrolysis of the β-γ phosphate bond by the ARF was 
established (Randazzo et al., 2000). The use of a highly conserved, 
catalytic arginine in GAP-stimulated GTP hydrolysis is also present 
in RHO GAPs (Barrett et al., 1997; Amin et al., 2016). Similar to 
many GAPs, the ARF GAP domain inserts the arginine finger into 
the nucleotide-binding site to stabilize the transition state of the 
reaction, and this requires the conserved glutamine in the switch 2 
region (Ismail et al., 2010; Cherfils and Zeghouf, 2013). Loss of 
GAP activity upon mutation of the arginine finger is fully consistent 
with its catalytic function. The arginine finger mechanism appears 
to be shared by both the ARF GAPs and ELMOD1-3, despite their 
disparate structures (East et al., 2012). Calcium stimulates the in 
vitro GAP activity of ASAP but not of other GAPs, while also com-
peting with its association to the membrane, again raising the 
intriguing issue of cross-talk between Ca2+ and ARF signaling 
(Ismail et al., 2010).
Regulating ARF GAPs
Membranes play a central role in regulating ArfGAPs, by restricting 
both their activities to specific subcellular locations and allosteric 
control of their GAP activity. Recruitment to membranes and 
allosteric activation of GAPs is commonly conferred by their PH 
domains, which are N-terminal to the GAP domains; this is true for 
the ASAP, ACAP, ARAP, and AGAP subfamilies (Kam et al., 2000; 
Nie et al., 2002; Campa et al., 2009; Jian et al., 2015) (Figure 3B). 
Other domains also contribute to regulating GAP activity. The 
curvature-sensing BAR domain of ASAP1 positions an autoinhibi-
tory motif to contact the PH and GAP domains, thus inhibiting 
GAP activity (Jian et al., 2009), while a BAR domain binding part-
ner, NM2A, stimulates ASAP1 activity, perhaps by relieving the 
autoinhibition (Chen et al., 2016). In a landmark study of ArfGAP1, 
recognition of membrane curvature by an ALPS motif, a peptide 
that folds as a helix to bind curved membranes, was shown to 
stimulate its GAP activity (Bigay et al., 2005). The catalytic activity 
of ArfGAP1 and ArfGAP2 also can be allosterically regulated by 
coatomer and cargo binding (Goldberg, 2000; Luo and Randazzo, 
2008; Luo et al., 2009). In another example, nonmuscle myosin 2A 
stimulates ASAP1 activity, perhaps by relieving autoinhibition 
(Chen et al., 2016).
For several ARF GAPs that function in FAs, including GITs, 
ASAP1, and AGAP2, targeting is achieved by binding to specific FA 
components (Turner et al., 2001; Randazzo et al., 2007; Vitali et al., 
2017). ARF GAPs that regulate the Golgi and endocytic compart-
ments also are targeted by binding to vesicle coat proteins, includ-
ing SMAPs binding through clathrin boxes to clathrin heavy chain 
and ArfGAP1 binding the δ-COP component of COPI coatomer 
(Tanabe et al., 2005; Natsume et al., 2006; Weimer et al., 2008; 
Spang et al., 2010; Suckling et al., 2015). These studies highlight the 
general principle, in which membrane and protein features that de-
fine the environmental conditions are coupled to the regulation of 
the GAP activity. They also show that specific mechanisms are re-
markably diverse, likely to allow diverse ARF functions, and the 
need to unravel these mechanisms to allow a clear understanding of 
ARF GAP functions in cells.
EVOLUTIONARY PARALLELS BETWEEN ARF GTPASES 
AND THEIR GEFS AND GAPS
The complexity of human ARF GTPases and their GEFs and GAPs 
presents a major challenge in defining their functionalities. An 
evolutionary approach can help by categorizing the proteins based 
on their evolutionary history and presence or absence in different 
organisms with diverging cell biologies (Figure 4A). It can also help 
to connect the human complement to that of other model (and 
nonmodel) organisms by detailing how the diversity of the human 
proteins arose. Functional diversity can most easily be conceptual-
ized as arising at three levels: 1) vertebrate-specific machinery that 
arose in the lineage giving rise to animals, 2) machinery present in 
the common ancestor of all eukaryotes, and 3) machinery present 
in the archaeal contributor to the origin of eukaryotes. The human 
complement of proteins in these three families includes a large 
number of subfamilies, shared among vertebrates, for example, 
humans, mice, rats, and fish. These are largely explained by the 
series of whole-genome duplications that took place at the dawn 
of vertebrates and gave rise to ARFs 1-5 (Manolea et al., 2010), 2-3 
paralogues in all ARF GAPs (except for ArfGAP1; Schlacht et al., 
2013), and 2-4 paralogues in almost all ARF GEFs (Figure 4B and 
Tables 2 and 3). The human complement also partly reflects expan-
sion of the families in the lineage that gave rise to animals, whether 
at the ancestor of all animals (i.e., holozoan) or of animals plus 
fungi (i.e., opisthokont). Examples include the duplication that 
gave rise to class I versus class II ARFs in holozoans (Manolea et al., 
2010), the emergence of the GAP ASAP (Schlacht et al., 2013), or 
that of the GEF EFA6, each of which arose in the opisthokonts (S. 
V. Pipaliya, A. Schlacht, C. M. Klinger, R. A. Kahn, and J. Dacks, 
personal communication). These are quite ancient (arising around 
a billion years ago; Eme et al., 2014), but still reflect ARF and regu-
latory machinery that is restricted to a relatively limited subset of 
eukaryotes, later expanded in vertebrates. We share these 
proteins with basal animal lineages and fungi, meaning that mole-
cular cell biological data from model organisms (e.g., Drosophila 
melanogaster, Caenorhabditis elegans, and S. cerevisiae) can 
meaningfully be applied to understand these proteins in human 
cells. However, there are no orthologues of these proteins in other 
eukaryotes, including plants, which likely reflects important func-
tional differences.
To understand ARF signaling and regulatory biology common to 
all eukaryotic organisms, we need to look for proteins that arose 
before the common ancestor of all eukaryotic life (around 2 billion 
years ago; Eme et al., 2014) and contributed common machinery in 
its descendent lineages. We know that this last eukaryotic common 
ancestor (LECA) was sophisticated, possessing a complement of 
membrane trafficking machinery that rivals that found in many eu-
karyotes today. LECA contained 16 ancient ARF GTPases, two of 
which were true ARFs (R. Petrželková and M. Eliáš, personal com-
munication). It also had six ARF GAPs (SMAP, AGFG, ArfGAP1, Arf-
GAP2, ACAP, ArfGAP_C2; Schlacht et al., 2013) (Figure 4A). This last 
protein is absent from human and yeast, but present in other 
eukaryotic lineages like plants and plant pathogens such as Phytop-
thora. The existence of ArfGAP_C2 highlights the fundamental 
eukaryotic cell biology left to be discovered, especially that not 
present in mammals. The LECA also possessed at least two 
ELMOD GAPs, which work on both ARFs and ARLs (East et al., 2012) 
(Figure 4A). GBF1 and BIG were also present in the LECA (Bui et al., 
2009), as was Cytohesin (S. V. Pipaliya et al., personal communica-
tion). Clearly, the complexity of ARF signaling had already been well 
developed at the dawn of eukaryotes. Recently, it has been possible 
to dig even deeper into the origins of ARFs with the discovery of 
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the Asgard archaea, metagenomic assemblies of what appear to 
be the closest living descendants of the archaeal lineage that 
contributed to the birth of eukaryotes (Spang et al., 2015; 
Zaremba-Niedzwiedzka et al., 2017). Within these genomes can 
be found GTPases that are not ARFs, ARLs, or SARs, but are 
clearly close relatives of the GTPases from which the ARF family 
later arose (Spang et al., 2015; Klinger et al., 2016). Examples of 
some proteins with domains similar to possible ARF GAPs and 
GEFs were also found, in some cases fused to the GTPases 
themselves.
Defining evolutionary patterns for the ARF, GEF, and GAP fami-
lies individually is extremely informative, but comparisons among 
the three families can be even more powerful. Human GAPs show 
very similar duplication patterns to the ARFs. Class I ARFs gave rise 
to ARFs 1-3, while class II ARFs gave rise to ARF4 and 5 (Manolea 
et al., 2010) (Figure 4B). The ARF GAPs show the same breakdown 
of two (ADAP, AGFG, GIT, SMAP) or three (ARFGAP, ACAP, AGAP, 
ARAP, ASAP) paralogues within these subfamilies (Schlacht et al., 
2013). This is a correlative observation, but raises testable models 
of coordinated activity of these proteins for which the substrate 
FIGURE 4: Evolution of the ARF family and its regulators. (A) The timing of the emergence of the relevant protein 
subfamilies is shown mapped on a simplified tree of eukaryotes. The polygons, circles, and squares denote the latest 
point by which the ARF GTPases, GAPs, and GEFs must have evolved, respectively, with the names of the subfamilies 
given to the right. The names of the eukaryotic supergroups are in italics, while the relevant “reconstructed ancestor” 
discussed in the text are in bold and noted by a dashed line. (B) Overlay of ARF1-5 evolution with that of the nine ARF 
GAP subfamilies that possess multiple paralogues. ARF evolution is depicted in black and Arf GAP in gray, with 
duplications at the base of Holozoa and Vertebrata. Relevant evolutionary transitions are illustrated by dashed lines.
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specificity and biological functions are poorly and incompletely un-
derstood. Whether the expansions in the GEFs reflect a coevolu-
tionary or functional relationship with the ARFs and GAPs is an open 
but exciting question. Interestingly, during the progressive expan-
sion of the ARFs and their regulatory machinery from the LECA to 
humans, some protein families have resisted expansion. There is 
only a single GBF1 (but two orthologues, Gea1 and Gea2, in yeast) 
and a single ArfGAP1, both of which act in the early secretory path-
way, suggesting a selective constraint on the plasticity of this path-
way, as compared with the late secretory and endocytic systems. 
Similarly, there is a single ARL2 that acts at multiple sites in distinct 
pathways but has resisted segregating those functions via duplica-
tion with paralogues having distinct localization and actions (Sharer 
and Kahn, 1999; Bowzard et al., 2005; Zhou et al., 2006; Newman 
et al., 2014). Evolutionary cell biology of cofunctioning families of 
proteins can reveal unexpected aspects of diverse organelle func-
tions (for examples, see Dacks and Robinson, 2017) and provide 
crossover insights into possible mechanisms of action and regula-
tory networks for each family. While the ARF family is typically de-
scribed as being one of four large families within the RAS superfam-
ily, the evolutionary analysis (Klinger et al., 2016), together with the 
unique and unifying structural mechanism employed by ARFs 
(Pasqualato et al., 2002; see also earlier discussion), argue that ARF 
GTPases form their own superfamily.
ARF GTPASES/GEFS/GAPS IN CANCER 
AND OTHER DISEASES
As for most small GTPases, ARFs (and their GEFs and GAPs) have 
been associated with human diseases, and many more roles in pa-
thologies continue to be discovered. A number of GTPases in the 
RAS superfamily have strong links to cancers, with RAS being the 
most commonly found mutated oncogene in human cancers and a 
RAS GAP, NF1, prominently altered in neurofibromatosis 
(Downward, 2003). We asked whether such links might be found 
within the human ARF families described herein. Interrogation of 
available next-generation sequencing data in the Cancer Genome 
Atlas (via http://cbioportal.com) reveals that ARF signaling is al-
tered in cancer (albeit less commonly than is RAS or RHO signal-
ing). Importantly, the mechanisms by which ARF GTPase/GEF/GAP 
signaling is genetically altered in cancers differs markedly from 
those seen in RAS and RHO families. RAS signaling is most com-
monly altered by missense mutation or amplification of the 
GTPases, deletion of RAS GAPs, and/or mutation of RAS effectors 
(Downward, 2003). Similarly, RHO signaling is most often altered 
by missense mutation or amplification of the GTPase, overexpres-
sion of GEFs, loss of GAPs, alterations in posttranslational modifi-
cations, and/or alternative splicing (Porter et al., 2016). In contrast, 
missense mutations that render ARF GAPs inactive are largely not 
observed, and the most common genetic alterations observed are 
amplification events, particularly of the GTPases ARF4 and ARL14 
and the ARF GAPs AGAP2 and ASAP1. ARF4 is commonly ampli-
fied in prostate cancer (20%) and is an important regulator of 
breast cancer cell migration (Jang et al., 2012). ARL14 has yet to 
be studied in the lab, but its high amplification rate in squamous 
cell lung cancer (23%), esophageal cancer (13%), and ovarian can-
cer (11%) merits further investigation. AGAP2 is often coamplified 
with CDK4 and promotes cancer cell survival, migration, and inva-
sion in glioblastoma models (Qi et al., 2017). ASAP1 expression 
correlates with metastatic potential in uveal melanoma, colon 
cancer, prostate cancer, and laryngeal squamous cell carcinoma 
(Ehlers et al., 2005; Muller et al., 2010; Li et al., 2014) and is associ-
ated with increased motility and invasiveness of uveal melanoma 
and breast cancer cells (Ehlers et al., 2005; Onodera et al., 2005). 
Furthermore, AGAP2 and ASAP1 amplification is associated with 
decreased overall and progression-free survival (Ehlers et al., 
2005). In addition, a number of reports implicate ARF4 (Jang et al., 
2012) and ARF6 (Hashimoto et al., 2004; Hongu et al., 2015; Li 
et al., 2017) in cancer cell migration, invasion, and metastasis. 
However, the molecular mechanisms through which the changes in 
ARF GTPases and their GAPs elicit pathology remain to be de-
fined. In addition to these amplification events, genomic deletions 
of at least one GTPase are observed. ARL11 (aka ADP-ribosylation 
factor-like tumor suppressor gene 1 [ARLTS1]), is commonly de-
leted in prostate cancer and sarcoma, and the expression of this 
gene in lung cancer is down-regulated due to promoter hyper-
methylation (Yendamuri et al., 2008). Likewise, the ARF GEF 
BRAG2 has been implicated in breast cancer and uveal melanoma 
(Morishige et al., 2008; Yoo et al., 2016).
Mutations in ARF GEFs have been identified as causes of human 
neurological disease. For example, a large number of mutations in 
BRAG1/IQSec2 have been identified and implicated in nonsyn-
dromic X-linked intellectual disability (Mignot et al., 2018), a subset 
of which occur within either the IQ motif or the Sec7d. These muta-
tions alter the trafficking of AMPA receptors in hippocampal neu-
rons, suggesting a molecular basis for the deficits in learning and 
memory associated with this disease. Schwann cell–specific deletion 
of BIG1 prevents myelination (Miyamoto et al., 2018), while muta-
tions in BIG2 cause periventricular heterotopia with microcephaly 
(Sheen et al., 2004; Lu et al., 2006; Grzmil et al., 2010). In both 
cases, we lack an understanding of the underlying mechanisms 
causing the GEF dysfunction.
TISSUE-SPECIFIC FUNCTIONS OF ARF 
GTPASES/GEFS/GAPS
There is growing evidence that at least some of these GTPases/
GEFs/GAPs (especially those arising late in evolution) show differ-
ential tissue expression patterns and act in a tissue-specific manner 
or are expressed and function during specific stages of develop-
ment. This is evident from studies in which specific GTPases have 
been mutated/deleted in mice (either total or tissue-specific knock-
out) and cause a variety of phenotypes (Table 4) (Mueller et al., 
2002; Schurmann et al., 2002; Schrick et al., 2006; Suzuki et al., 
2006; Caspary et al., 2007; Zahn et al., 2008; Hesse et al., 2010, 
2012; Hommel et al., 2010; Zhang et al., 2011; Jaschke et al., 2012; 
Akiyama et al., 2014; Hayakawa et al., 2014; Hongu et al., 2015; 
Hanke-Gogokhia et al., 2016, 2017; Huang et al., 2016; Li et al., 
2016; Lin et al., 2017; Bay et al., 2018; Dilan et al., 2018; Pearring 
et al., 2017; Rodiger et al., 2018). As might be expected for ancient 
and highly conserved proteins, several GTPases are essential, and 
their deletion results in embryonic lethality. However, the use of 
tissue-specific deletions provides a wealth of new information and 
highlights the importance of these proteins in cells, tissues, and 
whole organisms, as exemplified by deletions of ARF6 in endothe-
lial and neuronal cells as well as in platelets and podocytes and of 
the essential gene ARFRP1 in liver, adipocytes, or intestine (Table 4). 
Tissue-specific expression of designer mutations in GTPases/GEFs/
GAPs is another approach yielding novel insights (e.g., expression 
of the dominant active [Q70L]ARL2 in photoreceptor cells; Wright 
et al., 2018). There are also large efforts underway to systematically 
knock out each mouse gene, and these will add both key reagents 
and important information on the biology of the three families of 
proteins discussed herein. We did not include such data, but they 
can be found at the following sites: National Institutes of Health 
(NIH) Knockout Mouse Project (www.komp.org), Mouse Genome 
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Informatics (www.informatics.jax.org), and International Mouse Phe-
notyping Consortium (www.mousephenotype.org).
In addition, many ARF GTPase/GEF/GAP genes give rise to mul-
tiple splice isoforms, yet we know little or nothing about how the ex-
pression of such isoforms is regulated in different tissues, whether the 
isoforms have distinct cellular localizations, perform distinct actions, 
or are regulated through different mechanisms. For example, Cytohe-
sin 1 isoforms differing by the inclusion of a three-nucleotide glycine-
coding microexon in the PH domain display differential affinity for 
PI(4,5)P2 and PI(3,4,5)P3 and localize either to the PM (triglycine iso-
form) or to the leading edge (diglycine isoform) (Ratcliffe et al., 2018). 
Whether they perform different functions at those sites is unknown.
KEY QUESTIONS AND CHALLENGES
We reviewed key facets of current knowledge of ARF GTPases and 
their regulatory GEFs and GAPs. Here, we highlight what we con-
sider the most glaring deficiencies that, if addressed experimentally, 
will advance our understanding of the underlying mechanisms and 
regulation of a broad array of essential cell processes.
1. Functionalities of ARF family GTPases in cells: We are largely ig-
norant of how many different functions a single GTPase can per-
form in a cell, which GTPases support which cellular functions, 
and the extent to which functional redundancy between different 
GTPases occurs. In some cases, these functions may be very sim-
ilar (e.g., ARF1 regulating multiple steps of membrane traffick-
ing), while in others they may be distinct (e.g., ARL2 acting from 
the intermembrane space to regulate mitochondrial fusion and 
from the cytosol to regulate αβ-tubulin assembly). When a single 
GTPase performs multiple functions at distinct intracellular sites, 
how is its distribution regulated, and how are the distinct func-
tions coordinated to achieve integrated cellular homeostasis?
2. What subset of ARFs, GEFs, and GAPs is used in a given cellular 
response? It is well accepted that, if a regulatory GTPase is in-
volved in a specific pathway, it will need an upstream GEF and a 
downstream GAP/effector to serve that regulatory role. In vitro 
studies using purified components reconstituted on membranes 
provide a powerful means to decipher complex regulatory prop-
erties at the molecular level, determine affinities and specifici-
ties, and generate testable hypotheses to interrogate these 
mechanisms in the cell. However, in vitro conditions are poor 
mimetics of those in a cell, and it is challenging to identify how 
such mechanisms are mobilized, altered, or combined by the cell 
to generate a specific response.
3. ARF/GEF/GAP effectors/interactomes: We are largely ignorant 
of the proteins that bind to each GTPase/GEF/GAP and how 
such interactions influence their activity and/or downstream 
events. Do the effectors/interactomes differ depending on loca-
tion, and what defines the order, hierarchy, and cooperativity of 
such interactions? For example, do GEFs participate in the se-
lection of effectors, that is, do GEFs both activate ARFs and bind 
ARF effectors/GAPs to promote the specificity of the down-
stream event, perhaps serving as a scaffold, as shown for GBF1 
binding the γ-COP component of the coatomer (Deng et al., 
2009)? Our fragmentary knowledge of ARF family effectors and 
the downstream actions they perform is largely due to three 
technical difficulties. First, many GTPase-GAP/effector interac-
tions occur within the constricted diffusion of effectors “solid 
phased” on the membrane surface and have relatively weak af-
finities in solution, making many common techniques of interac-
tor identification (e.g., coimmunoprecipitation, affinity chroma-
tography, or copurification) of limited utility. Second, ARFs often 
work in concert with phospholipids in so-called coincidence de-
tection mechanisms, in which the interactions may require a par-
ticular lipid composition or membrane curvature. One example 
of this is the recruitment of the AP-1 clathrin adaptor complex to 
endosomal membranes, which requires its simultaneous binding 
to both ARF1 and the phosphoinositide PI(4)P (Ren et al., 2013). 
Identification of new ARF effectors may therefore require affinity 
isolation approaches that incorporate lipids. Just such an ap-
proach recently identified a lipid-dependent interaction be-
tween ARF1 and the actin regulatory WAVE complex (Koronakis 
et al., 2011). Third, most of these protein are cytosolic and may 
only transiently and incompletely associate with membranes to 
perform their key regulatory function(s), making it common for 
databases designed to catalogue localizations of proteins in 
cells or interactomes to miss important sites of action (e.g., 
compare our Figure 1 with data in the Human Protein Atlas: 
www.proteinatlas.org).
4. Posttranslational modifications: ARF GTPases/GEFs/GAPs are 
subject to posttranslational modifications that include phosphor-
ylation and ubiquitination. These modification are transient and 
are likely to play important roles in localization, activation, selec-
tion of binding partners, and biological outputs. However, very 
few studies have analyzed the consequences of posttranslational 
modifications on protein function(s) or identified the responsible 
kinase or other modifiers. We also are ignorant of how the func-
tional or metabolic status of a cell influences phosphorylation of 
specific proteins to evoke the appropriate functional response.
5. Identification of ARL GEFs and GAPs: This review focuses on the 
ARF GEFs and GAPs, largely because so little is known about the 
identity of ARL GEFs, GAPs, or effectors. Although ARLs com-
prise the largest group of the ARF family, we know the least 
about them and their regulators/interactors. We believe that the 
identification and characterization of each new GAP/GEF will 
provide important new insights into the regulation of essential 
cell processes. The finding that ELMODs, purified from mam-
malian tissues based on their GAP activity toward ARL2, also act 
on ARFs, showcases our ignorance of important and unexpected 
means of regulating ARFs as well as ARLs. Such studies increase 
the complexity and the challenges in sorting out specificities and 
pathways, but without such missing information, we risk funda-
mentally misinterpreting a lot of what we think we know about 
signaling by the ARF family.
SUMMARY
Surprisingly, despite decades of accumulated knowledge on ARF 
GTPases and their GEFs and GAPs, including an atomic understand-
ing of the GDP/GTP exchange and GTP hydrolysis reactions, we re-
main ignorant of fundamental and key aspects of their action and 
regulation. Defining the answers posed here for even a single pro-
tein is a daunting task for any investigator. Yet, we argue that study-
ing the entire ARF family of GTPases together and in concert with 
the families of their GEFs and GAPs will provide substantially more 
information and is critical to our understanding of 1) sources of spec-
ificity and functional redundancies, 2) complexities resulting from 
one protein acting at multiple sites, 3) enigmas of coordination be-
tween multiple GTPases to perform a single function, 4) the inter-
connections between ARF signaling and other cellular functions, and 
5) how the actions of the GTPases/GEFs/GAPs are integrated with 
cellular physiology and/or contribute to pathology when gone awry. 
No one laboratory can hope to make more than a small dent in the 
black box before us. Thus, we hope that this review might serve as 
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an argument in support of more collaborative efforts to address this 
large, complex, but vitally important field of ARF signaling.
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